Allogene Therapeutics Inc.

NASDAQ: ALLO
Share price (12/20/24): $1.87
Market cap (12/20/24): $392 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022 – amended

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Post-effective amendment to an automatic shelf registration

Prospectus supplement for primary offering

Ownership Filter

Messemer Deborah M.

Messemer Deborah M.

News Filter

Reports Third Quarter 2024 Financial Results and Business Update

Amendment to Code of Ethics, or Waiver of a Provision of the Code of Ethics, Financial Statements or Exhibits

Reports Second Quarter 2024 Financial Results and Business Update

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC

Letter from the SEC